
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.260 | 3.260 | 0.000 |
Shares | 96.740 | 96.740 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.791 | 30.421 |
Price to Book | 5.142 | 6.859 |
Price to Sales | 3.340 | 5.127 |
Price to Cash Flow | 16.892 | 18.349 |
Dividend Yield | 0.725 | 0.704 |
5 Years Earnings Growth | 13.481 | 11.846 |
Name | Net % | Category Average |
---|---|---|
Technology | 28.490 | 37.089 |
Healthcare | 17.400 | 12.061 |
Consumer Cyclical | 15.040 | 14.589 |
Industrials | 13.760 | 7.687 |
Communication Services | 8.990 | 12.936 |
Financial Services | 8.630 | 11.176 |
Consumer Defensive | 4.360 | 3.953 |
Basic Materials | 1.830 | 2.015 |
Real Estate | 0.780 | 2.205 |
Energy | 0.710 | 1.767 |
Number of long holdings: 199
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.89 | 524.11 | -1.76% | |
Broadcom | US11135F1012 | 3.88 | 288.64 | -1.72% | |
Amazon.com | US0231351067 | 2.78 | 214.75 | -8.27% | |
Transdigm | US8936411003 | 2.65 | 1,585.00 | -1.46% | |
Meta Platforms | US30303M1027 | 2.61 | 750.01 | -3.03% | |
Alphabet A | US02079K3059 | 2.18 | 189.13 | -1.44% | |
Mastercard | US57636Q1040 | 2.11 | 559.89 | -1.16% | |
Abbott Labs | US0028241000 | 1.83 | 127.29 | +0.87% | |
UnitedHealth | US91324P1021 | 1.80 | 237.77 | -4.72% | |
Eli Lilly | US5324571083 | 1.72 | 762.33 | +3.01% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1006075490 | 1.43B | -4.86 | 4.54 | 4.95 | ||
LU1481181243 | 572.86M | 15.46 | 13.21 | 7.11 | ||
LU1029763478 | 6.06B | -2.09 | 4.49 | 4.69 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review